The effects of rapid acting insulin on glucose control in basal-bolus insulin treated type2 diabetes.

The effects of rapid acting insulin on glucose control in basal-bolus insulin treated type2 diabetes. - The effects of rapid acting insulin on glucose control in basal-bolus insulin treated type2 diabetes.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012302

Enrollment

Registered

2013-11-20

Start date

2013-11-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Drug administration Drug administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients medicated with insulin Aspart 2. HbA1c value 7.0%-11%, type 2 diabetic patients

Exclusion criteria

Exclusion criteria: 1) Patients with hypersensitivity to insulin Aspart and/or Lispro. 2) Patients with surgical operation, trauma or infection. 3) Patients who are pregnant 4) Patients with severe renal or liver failure 5) Patients with pituitary insufficiency or adrenal insufficiency. 6) Patients with diarrhea or vomit 7) Patients with heavy exercise 8) Juged as ineligible by clinical investigators

Design outcomes

Primary

Measure	Time frame
the value of makers for glycemic control	—

Countries

Japan

Contacts

Public ContactTakaya Matsushita

Tokyo Medical University Hachioji Medical Center Diabetology, Endocrinology and Metabolism

tmatsush@tokyo-med.ac.jp042-665-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026